Consuming excessive salt is a well-established public health crisis, widely recognized for its role in driving hypertension and increasing the risk of cardiovascular disease. However, emerging scientific evidence suggests that the impact of a high-salt diet (HSD) extends far beyond blood pressure, potentially compromising memory, executive function, and emotional well-being. As researchers struggle to find effective interventions for these salt-induced neurological deficits, a new study from Japan has identified a potential nutritional solution: a soy-derived compound known as LPC70.<\/p>\n
The study, which was published online on May 14, 2026, and featured in Volume 197 of Neurochemistry International<\/em> on July 1, 2026, sheds light on how this specific ingredient\u2014a form of soy lysolecithin\u2014might act as a biological buffer against the systemic damage caused by sodium overload. By influencing complex chemical signaling pathways in both the kidneys and the brain, LPC70 appears to offer a dual-action protective effect, providing a glimmer of hope for future dietary strategies aimed at mitigating the cognitive and physical toll of modern, high-sodium lifestyles.<\/p>\n At the heart of the research is the intricate world of prostaglandins (PGs). These are potent, hormone-like lipid compounds synthesized from arachidonic acid (AA), a polyunsaturated fatty acid. In the human body, prostaglandins serve as critical local regulators, orchestrating a vast array of physiological processes.<\/p>\n In the cardiovascular system, they play a vital role in blood pressure homeostasis by modulating the constriction and dilation of blood vessels. When the system is balanced, this signaling helps maintain healthy circulation. However, their role in the brain is significantly more nuanced. Prostaglandins interact with various receptors, and depending on which pathways they activate, they can either act as neuroprotective agents or contribute to harmful inflammatory processes that degrade cognitive performance, memory retention, and emotional stability.<\/p>\n LPC70, a specialized form of soy lysolecithin where lysophosphatidylcholine (LPC) makes up more than 70% of the phospholipids, has been the subject of investigation by a team led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota. Based at the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals & Devices at Fujita Health University Graduate School of Medical Science, the researchers sought to uncover why this compound, which had shown efficacy in earlier, preliminary experiments, was able to counter both hypertensive and cognitive decline in mouse models. The team collaborated with Dr. Kazuhiro Kagotani of Tsuji Oil Mills Co., Ltd., and the Tsuji Health and Beauty Science Laboratory at Mie University, to map the precise molecular changes induced by the compound.<\/p>\n To evaluate the effects of LPC70, the research team placed mice on a high-salt diet and observed the resulting physiological changes. As anticipated, the salt-heavy diet triggered significant hypertension. Yet, the physical symptoms were only part of the story. <\/p>\n The behavioral analysis revealed that the mice began to exhibit signs of cognitive and social dysfunction. They showed a marked decrease in social interaction and struggled with object recognition memory\u2014a standard indicator of cognitive decline in animal models. Interestingly, the researchers noted that the mice did not experience widespread behavioral impairment; their overall motor function and anxiety levels remained largely unchanged. This specificity suggests that excessive salt selectively targets the neural circuits responsible for higher-order cognitive and social processes, rather than causing a global degradation of brain function.<\/p>\n When the researchers introduced LPC70 into the diets of these mice, the results were striking. Not only did the animals show a reduction in blood pressure, but they also regained performance levels in tests of social behavior and memory that were comparable to control groups. This prompted the researchers to delve into the molecular "why" behind these improvements, leading to an examination of kidney and brain tissue.<\/p>\n The researchers discovered that LPC70 exerts its influence in a highly site-specific manner, functioning differently depending on the organ system involved. In the kidneys, a high-salt diet was found to increase the expression of cyclooxygenase-2 (COX-2) and the PGE2 receptor EP3. Both are key components of the prostaglandin signaling pathway that can drive salt-sensitive hypertension. LPC70 effectively dampened these increases, essentially resetting the kidneys’ signaling environment to prevent the over-activation of mechanisms that drive up blood pressure.<\/p>\n The findings in the prefrontal cortex\u2014a critical hub for executive function, decision-making, and social cognition\u2014were distinct. In this brain region, high salt intake caused a downregulation of the PGD2 receptor DP1, a receptor linked to protective and anti-inflammatory signaling. By supplementing with LPC70, the researchers were able to restore the expression of DP1. Crucially, the compound did not affect the expression of DP2, a different receptor associated with potential nerve damage. This selectivity is a key finding: it suggests that LPC70 does not indiscriminately alter prostaglandin levels but rather selectively bolsters the protective pathways that the brain needs to combat the stress of a high-salt environment.<\/p>\n Perhaps the most surprising discovery involved the metabolism of arachidonic acid. Under high-salt conditions, the researchers observed lower levels of circulating arachidonic acid in the mice. One might assume that this scarcity would lead to a decrease in the production of downstream prostaglandins. However, when the mice were treated with LPC70, the levels of PGE2 and PGD2 actually increased.<\/p>\n This paradox points to a potential metabolic advantage: LPC70 may optimize the body\u2019s ability to utilize limited stores of arachidonic acid to synthesize the necessary signaling molecules. Essentially, the compound appears to act as a metabolic catalyst, ensuring that even under the taxing conditions of high sodium consumption, the body can maintain sufficient levels of protective prostaglandins to defend both cardiovascular and neurological integrity.<\/p>\n While these findings are promising, the research team is careful to note the boundaries of their work. The current study was conducted using animal models, and while the results provide a compelling roadmap for how LPC70 interacts with biological signaling, clinical trials in humans are necessary to determine if the same benefits translate to our species. <\/p>\n "We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," noted Professor Mouri. "Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd., a company that develops naturally derived food ingredients."<\/p>\n If human trials confirm these results, LPC70 could emerge as a powerful functional food ingredient. In an era where processed diets and high sodium intake are increasingly linked to the global rise in hypertension and age-related cognitive decline, a nutritional intervention that targets the underlying signaling pathways of these conditions could have a massive impact.<\/p>\n "Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," Professor Mouri concluded.<\/p>\n The depth of this investigation was made possible through extensive collaborative support. The research was funded by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS). Further support was provided by the Fujita Mind-Brain Research & Innovation Center for Drug Generation (Fujita Mind-BRIDGe) under Japan’s Peak Research Universities (J-PEAKS) Program, and the Japan Science and Technology Agency FOREST Program.<\/p>\n Additionally, Tsuji Oil Mills Co., Ltd. provided essential funding for the project. Further support was provided by the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation. These combined efforts highlight the growing interest in identifying, through rigorous scientific investigation, how naturally derived compounds can be leveraged to address the complex, systemic health challenges of the 21st century.<\/p>\n","protected":false},"excerpt":{"rendered":" Consuming excessive salt is a well-established public health crisis, widely recognized for its role in driving hypertension and increasing the risk of cardiovascular disease. However, emerging scientific evidence suggests that the impact of a high-salt diet (HSD) extends far beyond blood pressure, potentially compromising memory, executive function, and emotional well-being. As researchers struggle to find […]<\/p>\n","protected":false},"author":1,"featured_media":3470,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[370],"tags":[682,1473,2783,1933,5584,5587,195,5585,61,2685,5586,371,679,372],"class_list":["post-3471","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science-and-nature","tag-brain","tag-cardiovascular","tag-compound","tag-damage","tag-derived","tag-diets","tag-high","tag-mitigating","tag-nature","tag-promise","tag-salt","tag-science","tag-shows","tag-space"],"_links":{"self":[{"href":"https:\/\/xesi.net\/index.php?rest_route=\/wp\/v2\/posts\/3471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xesi.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xesi.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xesi.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/xesi.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3471"}],"version-history":[{"count":0,"href":"https:\/\/xesi.net\/index.php?rest_route=\/wp\/v2\/posts\/3471\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xesi.net\/index.php?rest_route=\/wp\/v2\/media\/3470"}],"wp:attachment":[{"href":"https:\/\/xesi.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xesi.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xesi.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}The Mechanism of Action: Prostaglandins and Signaling<\/h3>\n
Evaluating Cognitive and Physiological Impairment<\/h3>\n
Differential Protection: Kidneys vs. The Brain<\/h3>\n
A Breakthrough in Biochemical Efficiency<\/h3>\n
Implications for Human Health<\/h3>\n
Research Support and Acknowledgments<\/h3>\n